OTCMKTS:PKPH Peak Pharmaceuticals (PKPH) Stock Price, News & Analysis → Reclusive millionaire’s final warning about America (From Weiss Ratings) (Ad) Free PKPH Stock Alerts $2.10 0.00 (0.00%) (As of 06/17/2024 ET) Add Compare Share Share Today's Range$2.10▼$2.1050-Day Range$2.10▼$5.5552-Week Range$0.52▼$9.12Volume52 shsAverage Volume9,053 shsMarket Capitalization$823,200.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Get Peak Pharmaceuticals alerts: Email Address Ad Behind the MarketsWill this AI Micro-Cap be Bigger than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout AI stock. But right now... There's only ONE AI stock you should be watching.Get the full story here >>> About Peak Pharmaceuticals Stock (OTCMKTS:PKPH)Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.Read More PKPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PKPH Stock News HeadlinesMay 2, 2024 | bbc.co.ukDaytime and early peak commissioningMarch 5, 2024 | marketwatch.comAkari Therapeutics Signs Merger-of-Equals with Peak BioMarch 5, 2024 | markets.businessinsider.comAkari Therapeutics, Peak Bio Announces Agreement To Merge As Equals - Quick FactsJanuary 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Longboard Pharmaceuticals Amid Strong Bexicaserin Phase 2 Results and Blockbuster Revenue PotentialJune 14, 2023 | dailymail.co.ukPeak Practice is axedMay 31, 2023 | benzinga.comPeak Pharmaceuticals & Retrieve Medical Announce Signed Contract with Regional Medical CenterMay 31, 2023 | finance.yahoo.comPeak Pharmaceuticals & Retrieve Medical Announce Signed Contract with Regional Medical CenterMay 2, 2023 | usnews.comPeak to Peak Charter SchoolMarch 28, 2023 | finance.yahoo.comPeak Pharmaceuticals Merges with Retrieve Medical, Inc.February 23, 2023 | seekingalpha.comPKPHD Peak Pharmaceuticals, Inc.February 14, 2023 | finance.yahoo.comPeak Pharmaceuticals Announces One-for-Two-Hundred Reverse Stock SplitFebruary 14, 2023 | finanznachrichten.dePeak Pharmaceuticals, Inc.: Peak Pharmaceuticals Announces One-for-Two-Hundred Reverse Stock SplitFebruary 1, 2023 | seekingalpha.comMirum Pharmaceuticals: In The Spotlight Following Buyout Of Albireo PharmaJanuary 30, 2023 | cnbc.comBMO says this stock taking gene therapy to the 'next level' can more than doubleJanuary 10, 2023 | msn.comShould You Buy Biogen Stock After Its Latest Alzheimer's Disease Drug Approval?November 29, 2022 | cnbc.comHorizon Therapeutics fields buyout interest from Amgen, J&J and SanofiOctober 15, 2022 | seekingalpha.comPKPH Peak Pharmaceuticals, Inc.October 3, 2022 | reuters.comPeak Pharmaceuticals IncJune 14, 2022 | benzinga.comCannabis And PsychedelicsSeptember 9, 2021 | benzinga.comGood News For NY Cannabis Market Though Sales Won't Start Until 2023 Amid Regulatory UncertaintySeptember 9, 2021 | benzinga.comAUDACIOUS Teams Up With Professional Bull Riders On New CBD ProductsAugust 8, 2021 | benzinga.comGoing To Space Isn't The Only Way Jeff Bezos Wants To Get HighAugust 6, 2021 | barrons.comPeak Pharmaceuticals Inc.July 23, 2021 | benzinga.comNew York State Senator Aims To Speed Up Legal Cannabis Program Launch With New Cultivation BillSee More Headlines Receive PKPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Peak Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/17/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryCannabis Current SymbolOTCMKTS:PKPH CUSIPN/A CIK1452804 Webwww.peakpharma.com Phone(480) 659-6404FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-160,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-159.55% Debt Debt-to-Equity RatioN/A Current Ratio0.15 Quick Ratio0.15 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares392,000Free Float320,000Market Cap$823,200.00 OptionableNot Optionable Beta0.54 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesNeil ReithingerDirector, Chief Executive & Financial OfficerKey Competitors22nd Century GroupNASDAQ:XXIIHypha LabsOTCMKTS:DIGPLeafbuyer TechnologiesOTCMKTS:LBUYPervasipOTCMKTS:PVSPUnited CannabisOTCMKTS:CNABView All Competitors PKPH Stock Analysis - Frequently Asked Questions How have PKPH shares performed in 2024? Peak Pharmaceuticals' stock was trading at $1.73 at the beginning of 2024. Since then, PKPH shares have increased by 21.4% and is now trading at $2.10. View the best growth stocks for 2024 here. What other stocks do shareholders of Peak Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Peak Pharmaceuticals investors own include CNBX Pharmaceuticals (CNBX), Pennsylvania Real Estate Investment Trust (PEI), Medical Marijuana (MJNA), Organigram (OGI), Auxly Cannabis Group (CBWTF), GB Sciences (GBLX), GreenGro Technologies (GRNH), KushCo (KSHB) and MariMed (MRMD). How do I buy shares of Peak Pharmaceuticals? Shares of PKPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PKPH) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Peak Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Peak Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.